Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Aug 26, 2014; 6(8): 692-705
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.692
Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1
Rajamma Mathew
Rajamma Mathew, Section of Pediatric Cardiology, Maria Fareri Children’s Hospital, Valhalla, NY 10595, United States
Rajamma Mathew, Department of Physiology, New York Medical College, Valhalla, NY 10595, United States
Author contributions: Mathew R solely contributed to this paper.
Correspondence to: Rajamma Mathew, MD, Department of Physiology, New York Medical College, Valhalla, Basic Science Building, Rm #A11, Valhalla, NY10595, United States. rajamma_mathew@nymc.edu
Telephone: +1-914-5944750
Received: January 3, 2014
Revised: April 29, 2014
Accepted: June 27, 2014
Published online: August 26, 2014
Processing time: 257 Days and 13.3 Hours
Abstract

A number of disparate diseases can lead to pulmonary hypertension (PH), a serious disorder with a high morbidity and mortality rate. Recent studies suggest that the associated metabolic dysregulation may be an important factor adversely impacting the prognosis of PH. Furthermore, metabolic syndrome is associated with vascular diseases including PH. Inflammation plays a significant role both in PH and metabolic syndrome. Adipose tissue modulates lipid and glucose metabolism, and also produces pro- and anti-inflammatory adipokines that modulate vascular function and angiogenesis, suggesting a close functional relationship between the adipose tissue and the vasculature. Both caveolin-1, a cell membrane scaffolding protein and peroxisome proliferator-activated receptor (PPAR) γ, a ligand-activated transcription factor are abundantly expressed in the endothelial cells and adipocytes. Both caveolin-1 and PPARγ modulate proliferative and anti-apoptotic pathways, cell migration, inflammation, vascular homeostasis, and participate in lipid transport, triacylglyceride synthesis and glucose metabolism. Caveolin-1 and PPARγ regulate the production of adipokines and in turn are modulated by them. This review article summarizes the roles and inter-relationships of caveolin-1, PPARγ and adipokines in PH and metabolic syndrome.

Keywords: Adiponectin, Caveolin-1, Leptin, Metabolic Syndrome, Pulmonary hypertension, Peroxisome proliferator-activated receptor

Core tip: Pulmonary hypertension (PH) is a devastating disease with a high morbidity and mortality rate. Recent studies indicate that the metabolic alterations that occur during the course of PH have a negative effect. Importantly, PH has been observed in patients with metabolic syndrome. Caveolin-1, a membrane protein and peroxisome proliferator-activated receptor γ, a ligand activated transcription factor are abundantly expressed in vascular cells and adipocytes. They play a significant role in maintaining vascular health, and participate in glucose and lipid metabolism. Furthermore, the proximity of vasculature and adipose tissue facilitates reciprocal influence during health and disease.